179 related articles for article (PubMed ID: 36586043)
1. Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia.
Abo-El Fetoh ME; Abdel-Fattah MM; Mohamed WR; Ramadan LAA; Afify H
Inflammopharmacology; 2023 Feb; 31(1):499-516. PubMed ID: 36586043
[TBL] [Abstract][Full Text] [Related]
2. Probenecid ameliorates testosterone-induced benign prostatic hyperplasia: Implications of PGE-2 on ADAM-17/EGFR/ERK1/2 signaling cascade.
Abdel-Fattah MM; Abo-El Fetoh ME; Afify H; Ramadan LAA; Mohamed WR
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23450. PubMed ID: 37352135
[TBL] [Abstract][Full Text] [Related]
3. Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.
Bello II; Omigbodun A; Morhason-Bello I
BMC Urol; 2023 Dec; 23(1):207. PubMed ID: 38082261
[TBL] [Abstract][Full Text] [Related]
4. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia.
Quintero-García M; Delgado-González E; Sánchez-Tusie A; Vázquez M; Aceves C; Anguiano B
Free Radic Biol Med; 2018 Feb; 115():298-308. PubMed ID: 29248723
[TBL] [Abstract][Full Text] [Related]
5. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
Liu Y; Shao R; Suo T; Zhu J; Liu E; Wang Y; Miao L; Gao X
J Ethnopharmacol; 2023 Jun; 309():116354. PubMed ID: 36906158
[TBL] [Abstract][Full Text] [Related]
7. Ectodomain shedding of pro-TGF-alpha is required for COX-2 induction and cell survival in renal medullary cells exposed to osmotic stress.
Küper C; Bartels H; Fraek ML; Beck FX; Neuhofer W
Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1971-82. PubMed ID: 17942633
[TBL] [Abstract][Full Text] [Related]
8. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
10. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of Hydrocotyle ramiflora on testosterone-induced benign prostatic hyperplasia in rats.
Park S; Hwang YH; Baek EB; Hong EJ; Won YS; Kwun HJ
Int Urol Nephrol; 2023 Jan; 55(1):17-28. PubMed ID: 36107291
[TBL] [Abstract][Full Text] [Related]
13. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
Altavilla D; Minutoli L; Polito F; Irrera N; Arena S; Magno C; Rinaldi M; Burnett BP; Squadrito F; Bitto A
Br J Pharmacol; 2012 Sep; 167(1):95-108. PubMed ID: 22471974
[TBL] [Abstract][Full Text] [Related]
14. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
15. Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet.
Li Y; Shi B; Dong F; Zhu X; Liu B; Liu Y
Aging (Albany NY); 2019 Aug; 11(15):5570-5578. PubMed ID: 31412319
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia.
Xie C; Sun X; Chen J; Ng CF; Lau KM; Cai Z; Jiang X; Chan HC
J Cell Physiol; 2015 Aug; 230(8):1906-15. PubMed ID: 25546515
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.
Atawia RT; Mosli HH; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1131-40. PubMed ID: 25164963
[TBL] [Abstract][Full Text] [Related]
19. Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Adaramoye OA; Akanni OO; Abiola OJ; Owumi SE; Akinloye O; Olapade-Olaopa EO
Biomed Pharmacother; 2017 Nov; 95():1493-1503. PubMed ID: 28946212
[TBL] [Abstract][Full Text] [Related]
20. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
